ESMO Breast 2020: will you be among the contributors to the latest data in breast cancer? Submit your abstract by 4 February 2020
The latest standards in the field. Register by 20 November 2019 to discover them
There are many good reasons to become an ESMO member. Find out why you should join Europe's leading medical oncology society
Our journals offer ESMO members and the oncology community a globally visible platform to publish scientific studies, and a highly credible source of educational updates.
The ESMO-MCBS scale is a validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.
Dr. Florian Lordick expresses his enthusiasm for his appointment as ESMO Director of Education and shares his vision for the 2020-2021 Directorship
14 Nov 2019
The results of KEYNOTE-158 study
13 Nov 2019
Researchers uncover how immune checkpoint inhibitor response relies on the evolved efficiency of HLA-mediated immunity
12 Nov 2019
Evidence for efficacy is based on the results from the BELIEVE trial
11 Nov 2019
Webcasts and presentations can be accessed by ESMO members and event attendees
11 Nov 2019
Detection and management strategies
10 Nov 2019
The certificate will be available to print only upon completion of the online evaluation form
Vienna, Austria
14 Nov
- 17 Nov
2019
Singapore
20 Nov
- 21 Nov
2019
Singapore, Singapore
22 Nov
- 24 Nov
2019
Singapore
25 Nov
- 26 Nov
2019
Zurich, Switzerland
28 Nov
- 29 Nov
2019
Lugano, Switzerland
29 Nov
- 30 Nov
2019
